summUARY Samples which are taken for the Quick one-stage prothrombin time estimation for the control of patients receiving oral anticoagulant treatment are by convention taken into liquid sodium citrate anticoagulant. Dried sodium citrate has been rejected on the grounds that excessive haemolysis causes activation of clotting factors and therefore falsely short clotting times. Tests were performed with both liquid and dried sodium citrate as an anticoagulant for prothrombin time and Thrombotest. No clinically significant difference between the values given by the two anticoagulants was observed.
The control of oral anticoagulant treatment is normally effected either by measuring the prothrombin time (PT) and then calculating the prothrombin ratio (PR) or by using the Thrombotest technique. The preferred anticoagulant for the blood samples has usually been a sodium citrate solution as this, combined with good venepuncture technique, produces negligible haemolysis of red cells. The use of dried sodium citrate has been criticised by Mibashan' on the grounds that this produces a greater risk of haemolysis. It has been suggested that haemolysis could be associated with activation of clotting factors and consequently falsely short clotting times. This effect has not been properly documented.
The use of a liquid anticoagulant has certain potential disadvantages. Evaporation of the liquid during storage will alter the anticoagulant concentration after mixing with blood. In contrast, loss of anticoagulant solution from spillage, cracks in the container, or unauthorised removal before the blood is added will reduce the anticoagulant concentration. None of these problems arises with commercially available bottles containing dried citrate.
In view of the uncertainty of the magnitude of the effect of dried citrate, this was compared to a liquid citrate anticoagulant using blood from normal volunteers and from patients receiving oral anticoagulant treatment. The degree of haemolysis and 1090   220  280  340  370  600  1050  1110  780  720  380  180  360  260  180  490  790  720  260  150  275  325  355  190  120  280  225  250  250  490  290  225  15  390  290  35  205   780  540  455  840  155  835  250  630  370   200  370  305  270  505 % normal for dried citrate is 0 49 lower than for liquid citrate. Using the paired t test the difference is highly significant (p < 0 001).
The patients' group embraces a range of PR figures from 1 29 to 5 70 for liquid citrate. As might be expected there is a good correlation between the ratios for the two anticoagulants (r = 0-996, p < 0001) and the relation between the two ratios is expressed by the regression equation:
PR (dried) = 0 985 x PR (liquid) -0-029 If haemolysis has an important effect on the difference between the two PRs this may be obscured by a possible increase in discrepancy between the two ratios as the liquid ratio becomes larger. This was investigated using multiple regression coefficients and the model:
PR ( In view of these findings it is concluded that the convenience of using containers prepared with dried citrate makes them preferable for the collection of blood samples used to control oral anticoagulant treatment.
